At this time, there are over 120.000 patients waiting for transplant organs in the United States to have a second chance in life.
Η Harvard Apparatus Regenerative Technology, is a Boston company that develops synthetic trachea and plans to continue with the development of several organs, according to MIT Technology Review.
The trachea is made using the patient's stem cells, which are obtained from the bone marrow. The cells are grown on a scaffold made from fibers about a centimeter of the width of a human hair, which are then used to create a tube that is adapted to fit each patient.
Η HART is testing this new technique in Russia. Its aim is to continue testing in the European Union later this year and eventually in the United States.
HART developed the artificial tracheas in research labs, and plans to move the project to a facilitytreatments. In 2008, HART technology first enabled human transplantation of regenerative airways, and the company's current research has been applied during surgery four times so far.
The project could one day lead to creation and other synthetic organs, such as kidneys and heart valves, according to the MIT Technology Review.
